Cardiovascular & Thoracic Surgery

Medicine & Life Sciences

1. Heart-Assist Devices 100%
2. Transplants 58%
3. Coronary Artery Bypass 41%
4. Survival 39%
5. Heart Failure 38%
6. Equipment and Supplies 34%
7. Non-Small Cell Lung Carcinoma 34%
8. Extracorporeal Membrane Oxygenation 34%
9. Mitral Valve 33%
10. Mortality 32%
11. Blood Vessels 31%
12. Mitral Valve Insufficiency 30%
13. Aneurysm 30%
14. Thoracic Surgery 28%
15. Heart Transplantation 27%
16. Abdominal Aortic Aneurysm 26%
17. Therapeutics 26%
18. Heart 25%
19. Stroke 21%
20. Confidence Intervals 20%
21. Lower Extremity 20%
22. Limb Salvage 19%
23. Registries 18%
24. Lung Neoplasms 18%
25. Thorax 18%
26. Ischemia 18%
27. Surgeons 18%
28. Amputation 16%
29. Extremities 16%
30. Tissue Donors 15%
31. Stents 15%
32. Angioplasty 15%
33. Tricuspid Valve Insufficiency 15%
34. Veins 15%
35. Arteries 15%
36. Stem Cells 14%
37. Endoleak 13%
38. Hemorrhage 13%
39. Coronavirus 13%
40. Transcatheter Aortic Valve Replacement 13%
41. Thrombosis 13%
42. Cardiopulmonary Bypass 12%
43. Odds Ratio 12%
44. Randomized Controlled Trials 12%
45. Infections 12%
46. Renal Dialysis 12%
47. Lung 11%
48. Tricuspid Valve 11%
49. Femoral Artery 11%
50. Neoplasms 11%
51. Catheters 11%
52. Incidence 11%
53. Arteriovenous Fistula 10%
54. Saphenous Vein 10%
55. Atrial Fibrillation 10%
56. Databases 9%
57. Vena Cava Filters 9%
58. Pediatrics 9%
59. Multicenter Studies 9%
60. Annual Reports 9%
61. Aortic Valve 9%
62. Length of Stay 9%
63. Iliac Artery 9%
64. Costs and Cost Analysis 9%
65. Carotid Endarterectomy 9%
66. Peripheral Arterial Disease 9%
67. Wounds and Injuries 8%
68. Coronary Artery Disease 8%
69. Polytetrafluoroethylene 8%
70. Malpractice 8%
71. Morbidity 8%
72. Technology 8%
73. Angiography 8%
74. Clinical Trials 8%
75. Dissecting Aneurysm 8%
76. Left Ventricular Dysfunction 8%
77. Carotid Arteries 8%
78. Cardiomyopathies 8%
79. Transplantation 7%
80. Cardiogenic Shock 7%
81. Thoracic Aorta 7%
82. Erythrocyte Transfusion 7%
83. Safety 7%
84. Aortic Aneurysm 7%
85. Stroke Volume 7%
86. Rupture 7%
87. Systematic Reviews 7%
88. Transplant Recipients 7%
89. Pulmonary Embolism 7%
90. Neoadjuvant Therapy 6%
91. Pressure 6%
92. Venous Thrombosis 6%
93. Lung Transplantation 6%
94. Knee 6%
95. Robotics 6%
96. Hospitalization 6%
97. Primary Graft Dysfunction 6%
98. Gastric Bypass 6%
99. Jurisprudence 6%
100. Population 6%